Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/11/2008 First Published: 4/1/1999


1.		Phase III Randomized Study of Hormone Replacement Therapy in Menopausal or Perimenopausal Women With Prior Stage 0-II Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				Not specified				Other				ROC-HABITS EORTC-10992, IBCSG-17-98, SBG-HABITS, EU-98077, NCT00003771


2.		Phase II Pilot Endocrine Therapy with Sequential TMX and Estradiol plus Chemotherapy with High-Dose MTX/5-FU with Leucovorin Rescue in Patients with Metastatic Carcinoma of the Breast

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 75								NCOG-P-1B832 NCOG-P-1B-83-2

Last Modified: 9/1/1990


3.		Phase II Combined Modality Therapy with Hormonal Therapy Using Estradiol, Chemotherapy with FUVAC (5-FU/VBL/ADR/CTX) or FAC (5-FU/ADR/CTX), Radiotherapy, and Surgery in Patients with Advanced Stage III Breast Cancer (Summary Last Modified 09/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				SWOG-8568

Last Modified: 1/1/1992


4.		Phase II Study of Chemohormonal Therapy with ESDL/ZDX/VBL/DOX/TSPA in Patients with Metastatic Breast Cancer (Summary Last Modified 01/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 to physiologic 70				NCI				MSKCC-90094 NCI-T89-0232C, T89-0232

Last Modified: 11/12/2008 First Published: 11/10/2005


5.		Phase II Study of Transdermal Estradiol (Climara®) in Patients With Hormone- and Chemotherapy-Refractory Metastatic Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Over 18				NCI				CINJ-080419-5247 NJ 1805, CINJ-5155V2, NCT00255632, CINJ-NJ1805


6.		Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Other				05-5564-V 01 NCT00167648


7.		Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				04-0412 NCT00324259

Last Modified: 1/13/2009 First Published: 4/6/2007


8.		Phase II Study of Paclitaxel Poliglumex and Transdermal Estradiol in Patients With Androgen-Independent Stage IV Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				OHSU-2656 SOL-06048-L, NCT00459810

Select All on One Page